Neuroscience Center, University of Helsinki, Helsinki, Finland.
Neuroscience Center, University of Helsinki, Helsinki, Finland; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden; Center for Psychiatric Research, Stockholm City Council, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
Trends Neurosci. 2022 Jan;45(1):8-26. doi: 10.1016/j.tins.2021.11.002. Epub 2021 Dec 4.
Over a decade of schizophrenia research using human induced pluripotent stem cell (iPSC)-derived neural models has provided substantial data describing neurobiological characteristics of the disorder in vitro. Simultaneously, translation of the results into general mechanistic concepts underlying schizophrenia pathophysiology has been trailing behind. Given that modeling brain function using cell cultures is challenging, the gap between the in vitro models and schizophrenia as a clinical disorder has remained wide. In this review, we highlight reproducible findings and emerging trends in recent schizophrenia-related iPSC studies. We illuminate the relevance of the results in the context of human brain development, with a focus on processes coinciding with critical developmental periods for schizophrenia.
利用人类诱导多能干细胞(iPSC)衍生的神经模型进行精神分裂症研究已有十多年,这些研究提供了大量描述该疾病体外神经生物学特征的资料。与此同时,将这些结果转化为精神分裂症病理生理学的一般机制概念却一直滞后。鉴于使用细胞培养物来模拟大脑功能具有挑战性,因此体外模型与精神分裂症这一临床疾病之间的差距仍然很大。在这篇综述中,我们强调了最近与精神分裂症相关的 iPSC 研究中的可重复发现和新兴趋势。我们根据人类大脑发育的情况来阐明研究结果的相关性,重点关注与精神分裂症关键发育期相吻合的过程。